Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40.8M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
36.3M
-
Shares change
-
+99K
-
Total reported value, excl. options
-
$93.9M
-
Value change
-
-$4.6M
-
Number of buys
-
58
-
Number of sells
-
-59
-
Price
-
$2.59
Significant Holders of Pulmonx Corp - COM (LUNG) as of Q2 2025
143 filings reported holding LUNG - Pulmonx Corp - COM as of Q2 2025.
Pulmonx Corp - COM (LUNG) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.3M shares
of 40.8M outstanding shares and own 88.95% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (5.16M shares), FMR LLC (4.26M shares), MORGAN STANLEY (3.56M shares), BlackRock, Inc. (2.69M shares), VANGUARD GROUP INC (2.29M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (1.89M shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (1.17M shares), MILLENNIUM MANAGEMENT LLC (1.17M shares), DEUTSCHE BANK AG\ (1.13M shares), and Silvercrest Asset Management Group LLC (931K shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.